Ixekizumab: an alternative for HIV-positive psoriasis patients.

IF 2.1 4区 医学 Q3 INFECTIOUS DISEASES AIDS Research and Therapy Pub Date : 2024-11-28 DOI:10.1186/s12981-024-00675-8
Fanghua Liu, Zhou Liu, Rongming Yang, Dandan Huang, Yongzhi Han
{"title":"Ixekizumab: an alternative for HIV-positive psoriasis patients.","authors":"Fanghua Liu, Zhou Liu, Rongming Yang, Dandan Huang, Yongzhi Han","doi":"10.1186/s12981-024-00675-8","DOIUrl":null,"url":null,"abstract":"<p><p>Psoriasis is a recurrent and protracted inflammatory disease. Generalized erythema, plaques, and silvery scales on the surface mainly characterize its skin lesions. Biologics bring new hope to psoriasis patients. However, HIV infection is a major concern before receiving biologics. Here, we present a case of the efficacy and safety of Ixekizumab, an interleukin 17 inhibitor, in the treatment of psoriasis patients living with HIV (PPLHIV).</p>","PeriodicalId":7503,"journal":{"name":"AIDS Research and Therapy","volume":"21 1","pages":"87"},"PeriodicalIF":2.1000,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AIDS Research and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12981-024-00675-8","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Psoriasis is a recurrent and protracted inflammatory disease. Generalized erythema, plaques, and silvery scales on the surface mainly characterize its skin lesions. Biologics bring new hope to psoriasis patients. However, HIV infection is a major concern before receiving biologics. Here, we present a case of the efficacy and safety of Ixekizumab, an interleukin 17 inhibitor, in the treatment of psoriasis patients living with HIV (PPLHIV).

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Ixekizumab:HIV 阳性银屑病患者的另一种选择。
银屑病是一种反复发作、久治不愈的炎症性疾病。皮损以泛发性红斑、斑块和表面银白色鳞屑为主。生物制剂为银屑病患者带来了新希望。然而,在接受生物制剂治疗之前,艾滋病病毒感染是一个主要问题。在此,我们介绍了白细胞介素 17 抑制剂 Ixekizumab 治疗感染艾滋病毒的银屑病患者(PPLHIV)的有效性和安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
AIDS Research and Therapy
AIDS Research and Therapy INFECTIOUS DISEASES-
CiteScore
3.80
自引率
4.50%
发文量
51
审稿时长
16 weeks
期刊介绍: AIDS Research and Therapy publishes articles on basic science, translational, clinical, social, epidemiological, behavioral and educational sciences articles focused on the treatment and prevention of HIV/AIDS, and the search for the cure. The Journal publishes articles on novel and developing treatment strategies for AIDS as well as on the outcomes of established treatment strategies. Original research articles on animal models that form an essential part of the AIDS treatment research are also considered
期刊最新文献
Ixekizumab: an alternative for HIV-positive psoriasis patients. Brief communication: efficacy and safety of the dolutegravir/lamivudine dual therapy in antiretroviral treatment-experienced Chinese people living with HIV. Compliance with reporting standards in Mobile App interventions for ART Adherence among PLHIV. Traditional complementary and alternative medicine (TCAM) use among PLHIV on antiretroviral medication. Clustering affordable care act qualified health plans to understand how and where insurance facilitates or impedes access to HIV prevention.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1